Addison Capital CO Teva Pharmaceutical Industries LTD Transaction History

Addison Capital CO

$238 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$7.48 - $10.7 $6,171 - $8,827	-825 Reduced 1.95%	41,413 $422,000
Q2 2023 Aug 18, 2023	SELL	$7.2 - $9.47 $1,980 - $2,604	-275 Reduced 0.65%	42,238 $318,000
Q2 2022 Jul 11, 2022	SELL	$7.38 - $10.4 $1,107 - $1,560	-150 Reduced 0.35%	42,513 $320,000
Q1 2022 Apr 11, 2022	SELL	$7.33 - $9.39 $2,052 - $2,629	-280 Reduced 0.65%	42,663 $401,000
Q4 2021 Jan 18, 2022	SELL	$7.9 - $10.19 $276 - $356	-35 Reduced 0.08%	42,943 $344,000
Q3 2021 Oct 12, 2021	SELL	$8.38 - $10.18 $419 - $509	-50 Reduced 0.12%	42,978 $419,000
Q2 2021 Jul 16, 2021	BUY	$9.9 - $11.56 $51,876 - $60,574	5,240 Added 13.87%	43,028 $426,000
Q4 2020 Jan 12, 2021	SELL	$8.61 - $11.04 $5,940 - $7,617	-690 Reduced 1.79%	37,788 $365,000
Q3 2020 Oct 13, 2020	SELL	$8.57 - $12.69 $882 - $1,307	-103 Reduced 0.27%	38,478 $347,000
Q2 2020 Jul 16, 2020	SELL	$8.12 - $13.12 $30,246 - $48,872	-3,725 Reduced 8.8%	38,581 $476,000
Q1 2020 Apr 13, 2020	BUY	$6.69 - $13.45 $26,760 - $53,800	4,000 Added 10.44%	42,306 $380,000
Q4 2019 Jan 10, 2020	SELL	$6.53 - $10.72 $28,274 - $46,417	-4,330 Reduced 10.16%	38,306 $375,000
Q3 2019 Oct 10, 2019	SELL	$6.16 - $9.6 $800 - $1,248	-130 Reduced 0.3%	42,636 $293,000
Q2 2019 Jul 11, 2019	SELL	$8.12 - $15.72 $126,404 - $244,713	-15,567 Reduced 26.69%	42,766 $395,000
Q1 2019 Apr 10, 2019	SELL	$15.58 - $20.01 $22,435 - $28,814	-1,440 Reduced 2.41%	58,333 $915,000
Q4 2018 Jan 16, 2019	SELL	$14.59 - $23.84 $114,268 - $186,714	-7,832 Reduced 11.58%	59,773 $922,000
Q3 2018 Oct 09, 2018	BUY	$21.06 - $25.65 $327,925 - $399,396	15,571 Added 29.92%	67,605 $1.46 Million
Q2 2018 Jul 11, 2018	SELL	$16.77 - $24.71 $5,366 - $7,907	-320 Reduced 0.61%	52,034 $1.27 Million
Q1 2018 Apr 10, 2018	BUY	$16.68 - $22.07 $2,251 - $2,979	135 Added 0.26%	52,354 $895,000
Q4 2017 Jan 19, 2018	SELL	$11.23 - $19.1 $50,029 - $85,090	-4,455 Reduced 7.86%	52,219 $990,000
Q3 2017 Oct 17, 2017	BUY	$15.41 - $32.17 $873,346 - $1.82 Million	56,674	56,674 $997,000

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

565M

Call Options Held

25.2M

Put Options Held

5.08M

Black Rock Inc. New York, NY

43M
Shares

$736 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.3M
Shares

$622 Million
41.14% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

32.3M
Shares

$553 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$493 Million
3.23% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$453 Million
15.49% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Addison Capital CO, based on Form 13F filings with the SEC.

News

Stay updated on Addison Capital CO with notifications on news.

Account